key: cord-1019894-e3qggvbj
authors: Petersen, Antonia; Bressem, Keno; Albrecht, Jakob; Thieß, Hans-Martin; Vahldiek, Janis; Hamm, Bernd; Makowski, Marcus R.; Niehues, Alexandra; Niehues, Stefan; Adams, Lisa C.
title: The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany
date: 2020-07-14
journal: Metabolism
DOI: 10.1016/j.metabol.2020.154317
sha: 1a1ab856aba48ef5b149351e7b0b0efbac600032
doc_id: 1019894
cord_uid: e3qggvbj

BACKGROUND AND AIMS. Overall obesity has recently been established as an independent risk factor for critical illness in patients with coronavirus disease 2019 (COVID-19). The role of fat distribution and especially that of visceral fat, which is often associated with metabolic syndrome, remains unclear. Therefore, this study aims at investigating the association between fat distribution and COVID-19 severity. METHODS: Thirty patients with COVID-19 and a mean age of 65.6 ± 13.1 years from a level-one medical center in Berlin, Germany, were included in the present cross-sectional analysis. COVID-19 was confirmed by polymerase chain reaction (PCR) from nasal and throat swabs. A severe clinical course of COVID-19 was defined by hospitalization in the intensive care unit (ICU) and/or invasive mechanical ventilation. Fat was measured at the level of the first lumbar vertebra on routinely acquired low-dose chest computed tomography (CT). RESULTS: An increase in visceral fat area (VFA) by ten square centimeters was associated with a 1.37-fold higher likelihood of ICU treatment and a 1.32-fold higher likelihood of mechanical ventilation (adjusted for age and sex). For upper abdominal circumference, each additional centimeter of circumference was associated with a 1.13-fold higher likelihood of ICU treatment and a 1.25-fold higher likelihood of mechanical ventilation. CONCLUSIONS: Our proof-of-concept study suggests that visceral adipose tissue and upper abdominal circumference specifically increase the likelihood of COVID-19 severity. CT-based quantification of visceral adipose tissue and upper abdominal circumference in routine chest CTs may therefore be a simple tool for risk assessment in COVID-19 patients.

In the context of the current unprecedented health crisis due to the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evidence has emerged suggesting that obesity might aggravate the course of coronavirus disease 2019 COVID-19 [1, 2] . However, previous research has focused exclusively on an increased individual body mass index (BMI) as a risk factor for severe COVID-19 without distinguishing between subcutaneous and visceral adipose tissue. Apart from overall obesity, body fat distribution is an important risk factor for cardiometabolic outcome [1, 2] . Visceral adipose tissue is often associated with metabolic syndrome, conferring an increased risk of cardiovascular disease and type 2 diabetes mellitus with subsequent higher morbidity [1, 2] . Furthermore, although BMI is currently the most commonly used indicator for assessing overweight/obesity in adults and has high specificity, it is influenced by sex and age and has an inherently low sensitivity for identifying excess fat mass [3] . Furthermore, BMI-based measures cannot distinguish between visceral and subcutaneous fat.

Here, computed tomography (CT) with noninvasive postprocessing tools enables the differentiation and quantification of visceral and subcutaneous fat tissue, thus allowing reliable assessment of body fat distribution [4] .

Therefore, the aim of this proof-of-concept study was to quantify the subcutaneous and visceral adipose tissue of COVID-19 patients using routinely acquired chest CT scans and to compare the results with the severity of the clinical course in terms of hospitalization with intensive care unit (ICU) treatment and/or invasive mechanical ventilation.

J o u r n a l P r e -p r o o f 5

Thirty patients with COVID-19 and a mean age of 65.6 ± 13.1 years from a level-one medical center in Berlin, Germany, were included in the present cross-sectional analysis. Patients were treated between March 27 and April 27, 2020 and inclusion criteria were: availability of a (lowdose) chest CT scan with diagnostic image quality and laboratory-confirmed COVID-19. All CT datasets were of diagnostic image quality and none of the patients had to be excluded. was confirmed by polymerase chain reaction (PCR) from nasal and throat swabs on the day of admission. To reduce the false negative rate, at least two repeat PCRs were performed.

Additional swabs were obtained to confirm the diagnosis in patients with a positive result and in case of negative results and persisting respiratory symptoms. A severe course of COVID-19 was defined by the requirement of ICU treatment and/or mechanical ventilation. Age and sex were potential confounders, which were corrected for in statistical analysis.

This proof-of-concept study was prior approved by the local ethics committee in accordance with the local laws and regulations, including a waiver of informed consent (EA 4/140/17). It was conducted in accordance with the local laws and regulations and in accordance with the Declaration of Helsinki and Good Clinical Practice.

CT examinations of study patients were performed on two different types of scanners: three Canon Aquilion PRIME (CAP) scanners and a GE Lightspeed VCT (GEL) scanner. A low-dose chest CT scan was performed for diagnostic purposes or to evaluate the patient's current condition on the day of admission. The CT protocol included the following imaging parameters: Patients were positioned supine, and nonenhanced scans in caudocranial scan direction were obtained in deep inspiration. We reconstructed 0.5 mm (CAP) and 0.625 mm (GEL) axial slices using soft tissue and lung kernels (Fc01 and Fc85 (CAP), "standard" and "lung" (GEL)) and iterative reconstruction technology (AIDR3D level "moderate" (CAP), ASIR 50% (GEL)).

CT fat was measured in a fully automated fashion from chest CTs using Vital's Vitrea ™ Advanced Visualization postprocessing applications (Version 7.0, Canon Medical Systems Cooperation, Otawara, Tochigi, Japan)., which was designed to isolate and quantify subcutaneous and visceral fat tissue based on a single slice of non-contrast enhanced CT data.

Visceral fat area (VFA), subcutaneous fat area (SFA), and total fat area (TFA) were quantified at the level of the mid of the first lumbar vertebra on clinical chest CT scans routinely acquired for COVID-19 [5, 6] ). Data were then exported as comma-separated values.

As outcome of interest we defined whether the patient had to be transferred to the intensive care unit and if mechanical ventilation was required. The Radiology Information System was searched to determine if the patient had to be been transferred to the ICU and conventional chest radiographs were assessed to assess if patients were intubated.

Other patient information such as age, weight, or height were extracted from the DICOM headers of the CT scans, if available. If this information was missing in the DICOM headers, it was instead extracted from patient reports, resulting in no missing data on age, weight or height. BMI was calculated according to the common formula: weight (kg) / [height (m)] 2 . Other clinical J o u r n a l P r e -p r o o f 7 information, such as comorbidities and laboratory data, were also extracted from patient records.

Regarding comorbidities, we assumed a comorbidity was not present if not mentioned in any of the patient records over the last five years. Acquired data were stored in tabular form and then exported as comma-separated values for subsequent statistical analysis.

All statistical analysis was performed using the 'R' statistical environment (Version 4.0.0), including the "tidyverse" library [7, 8] ). Continuous variables were tested for normal distribution using the Shapiro-Wilk test. If normally distributed, they were expressed as mean ± standard deviation. Otherwise, they were presented as median and interquartile range (IQR). Spearman's correlation coefficients were calculated, if correlations were assessed. The three subgroups of patients (normal ward, ICU, and mechanical ventilation) were compared using an analysis of variance with mixed models corrected for age and sex, with the imaging site as random intercept.

Afterwards, post-hoc binary tests were applied to compare patients on normal wards with ICU patients and patients on wards with patients requiring mechanical ventilation. Continuous and normally distributed variables were compared with a one-tailed Student's t-test, while the Wilcox rank sum test was used in case of non-normal distribution. Categorical variables were expressed as frequencies and percentages and compared using Fisher's exact test or the Chi-squared test, as appropriate. A multivariate binomial logistic regression model was employed to analyze the relationship between severe clinical courses and quantitative CT features. 95% confidence intervals for odds ratios were calculated using bootstrapping (1000 iterations). A p-value < 0.05 was considered statistically significant.

In the present proof-of-concept study, we analyzed chest CT images of 30 patients with confirmed SARS-CoV-2 infection. The study population had a mean age of 65.6 years ± 13.1 years and included 18 men (61.9 years ± 12.8 years) and 12 women (71.2 years ± 11.8 years, p = 0.051). A total of 43 % of the patients had to be transferred to the ICU during treatment (n = 13), with men being affected more often than women (9 men vs. 4 women, p = 0.47). Seven of the 13 ICU patients required mechanical ventilation (6 men vs. 1 woman, p = 0.19). Information on height and weight was available in all cases. Tables 1 to 3 provide detailed overviews of anthropomorphic and clinical patient characteristics.

Mean BMI of all patients was 26.4 kg/m² ± 2.9 kg/m² (men 26.0 kg/m² ± 2.24 kg/m² vs. women 26.9 kg/m² ± 3.7 kg/m²). Patients who were admitted to the ICU had a BMI of 26.8 kg/m² ± 2.1 kg/m² compared to patients who did not require ICU treatment with a BMI of 26.1. kg/m² ± 3.4. kg/m² This difference was not significant (p = 0.46).

The median VFA was 82.4 cm 2 (IQR 55.2 cm 2 ). Men tended to have more visceral adipose tissue than women (95.4 cm 2 vs. 67.3 cm 2 ), and the difference was statistically significant (p = 0.014).

Patients admitted to the ICU had a significantly larger TFA compared to patients in the normal ward. When looking at the different fat compartments, it was particularly conspicuous that ICU patients had a significantly larger VFA (96.9 cm 2 ± 33.5 cm 2 ) compared to patients in the normal ward (70.0 cm 2 ± 28.2 cm 2 , p = 0.031). Furthermore, patients requiring mechanical ventilation had a significantly larger VFA than patients who could breathe freely (ICU with mechanical ventilation: 124.2 cm 2 vs. ICU and free breathing: 96.6 cm 2 vs. normal ward and free breathing: patients on the normal ward (99.2 cm ± 8.0 cm, p = 0.009) and similarly between patients requiring mechanical ventilation (109.7 cm ± 7.6 cm) and patients without mechanical ventilation (103.8 ± 8.6, p = 0.008).

Differences in SFA between patients on the normal ward vs. ICU or patients with vs. without mechanical ventilation were also significant (p = 0.039), but with only low statistical power (0.38). The differences in the various fat tissue measurements and BMI between patient groups are summarized in Table 4 . Figure 2 provides an overview of the distribution of the different BMI and fat measures.

VFA and BMI showed a moderate correlation with a correlation coefficient of r = 0.53 (95% CI 0.40 -0.73, p < 0.001). It is noteworthy that the correlation was stronger for men than for women (r = 0.59 vs. r = 0.52). CT-derived upper abdominal circumference and BMI also showed a moderate correlation with a correlation coefficient of r = 0.59 (95% CI 0.41 -0.78, p < 0.001).

Again, men showed a slightly stronger correlation between BMI and CT-derived upper abdominal circumference compared to women (r = 0.62 vs. r = 0.58).

As VFA and CT-derived upper abdominal circumference differed significantly between patients who required ICU treatment and/or mechanical ventilation and patients who did not require ICU treatment or mechanical ventilation, a logistic regression analysis was conducted. Two models each were constructed for VFA and CT-derived upper abdominal circumference, the first unadjusted for any confounder, the second adjusted for age and sex. Table 5 gives an overview of Journal Pre-proof the odds ratios derived from logistic regression analysis. An increase in VFA by 10 square centimeters was associated with a higher likelihood of ICU treatment and a higher likelihood of mechanical ventilation. The odds ratio, as derived from the model adjusted for age and sex, was 1.37 (95% CI 1.07 -1.89) regarding ICU treatment. This means that patients were 1.37 times more likely to require ICU treatment than patients with 10 cm 2 less VFA. Similarly, those patients were also 1.32 (95% CI 1.04 -1.91) times more likely to require mechanical ventilation compared to patients with 10 cm 2 less VFA. In 2016, the World Health Organization estimated that 1.9 billion adults were overweight and of these, over 650 million were obese [9] . Overall obesity is a state of low-grade systemic inflammation, which contributes to the development of metabolic diseases, such as dyslipidemia or type 2 diabetes mellitus, and may modify immune responses, making the immune system more susceptible to infection [10] . This could also play an important role in the pathogenesis of respiratory disorders [11] . In the context of influenza virus infection, obesity has been suggested to impair memory CD8+ T cell responses to infection, resulting in more severe lung pathology and higher mortality [12] . Particularly central obesity with intra-abdominal deposition of visceral fat tissue has been closely linked to cardiometabolic disorders [13] . Visceral adipose tissue, known to be more metabolically active than subcutaneous adipose tissue, has unique endocrine functions and secretes a variety of adipokines and pro-inflammatory cytokines, including TNF, C-reactive protein, interleukin 6 (IL-6), and leptin [12, 14] . Apart from insulin resistance and metabolic syndrome, elevated IL-6 levels are known to be related to chronic inflammatory airways disease, and recent studies report higher levels of IL-6 in COVID-19 non-survivors [15, J o u r n a l P r e -p r o o f 12 16] . Early findings from Italy suggest that IL-6 receptor inhibition by administration of the monoclonal antibody tocilizumab might improve respiratory function in COVID-19-related acute respiratory distress syndrome [17] . In addition, leptin was previously found to be related to airway reactivity, and initial findings suggests that leptin levels are elevated in COVID-19 patients with more severe pulmonary inflammation [18, 19] .

With the shift of COVID-19 epicenters to Europe and now especially North and South America, the impact of obesity on COVID-19 may gain in importance, as these two continents have some of the highest prevalence of obesity worldwide, with obesity taking on epidemic proportions [20] ). While previous investigators already identified overall obesity as a risk factor for severe courses of COVID-19, they only used BMI to measure obesity [21] [22] [23] [24] . Compared to recent COVID-19 studies from New York and Lille [24, 25] , which used BMI as a measure of obesity, our ICU patients were of similar age (65.6 ± 13.1 years) as the patients from New York (median 67, ICR 56 -77 years), while patients from Lille were younger (median 60, ICR 51 -70 years) [26] . Regarding median BMI, the Lille center found that COVID-19 patients with a BMI ≥ 35 kg/m 2 required mechanical ventilation significantly more often than COVID-19 patients with a BMI below 25 kg/m 2 [24] ). In a New York patient population, especially a BMI ≥ 40 kg/m 2 was identified to be among the factors most strongly associated with hospitalization of COVID-19 patients [25] . Another study from New York by Palaiodimos et al. examined a minoritypredominant population and found that severe obesity was independently associated with a higher in-hospital mortality [27] . Zheng et al. reported patients with metabolic associated fatty liver disease and obesity (BMI > 25 kg/m 2 ) to have a 6-fold higher risk for a severe course of COVID-19 [2] . By comparison, we found a more than 1.37-fold higher likelihood of ICU treatment and a J o u r n a l P r e -p r o o f 13 more than 1.32-fold higher likelihood of mechanical ventilation for an increase in VFA by 10 square centimeters (adjusted for age and sex).

A current study by Deng et al. found that obesity could also increase severe courses of COVID-19 in younger patients, especially in those with damages of liver and kidneys [28] . Kass It should be noted that the utility of BMI in assessing obesity depends on the assumption of a close correlation of anthropomorphic measures with direct measures of obesity, such as total body fat or visceral and subcutaneous adipose tissue [24] . Here, several studies suggest that, for the same BMI, the amount of body fat is heavily influenced by age and sex, as women tend to have more fat than men with the same BMI, while older persons tend to have more body fat than younger persons with the same BMI [31, 32] . This is in line with our correlation coefficient of 0.56 for VFA and BMI and the consistently moderate correlation coefficients reported in the literature, ranging from 0.61 to 0.71 after adjustment for age [26, 33, 34] .

By using CT-based quantification of the visceral and subcutaneous adipose tissue, we chose a more comprehensive approach to measure potential obesity, which allowed us to separately determine different fat compartments such as the subcutaneous and visceral fat area. This is essential as body fat distribution was previously established as an independent risk factor for cardiometabolic outcomes in the general population, next to obesity [2] . Although the post-J o u r n a l P r e -p r o o f 14 processing application used in the present study (Vitrea ™ ) was not previously validated for fat measurement in COVID-19 patients, it has been validated for abdominal fat measurement by using cryosection photographs and CT images from the NIH Visible Human Project [35, 36] . In addition, it was reported that visceral fat areas obtained from a single slice and waist circumference obtained at the level of the umbilicus (approximately L4 or L5) were highly correlated to the total visceral fat volume [37, 38] . Here, it has to be pointed out, that we obtained the fat measurements at the level of the first lumbar vertebra instead of the fourth or fifth vertebra, as the lower levels were not included in the chest CT scans. Kuk et al. previously investigated if the measurement site for visceral and abdominal subcutaneous adipose tissue in CT scans would alter associations with the metabolic syndrome and found no significant difference between Th12-L1, L1-2 and L4-L5 [39] . Therefore, it appears that the first lumbar vertebra (L1) may similarly be used for fat measurement. Still, our deviating measurement method (measurement at the level of L1 instead of L4/5) has to be recognized as a potential shortcoming.

In our COVID-19 population we found that -apart from TFA -VFA and CT-derived upper abdominal circumference were associated with ICU treatment and/or mechanical ventilation.

Differences in SFA were also statistically significant, but with only low statistical power, while BMI did not show any significant association with severe courses of COVID-19. However, it has to be acknowledged that the mean BMI was quite low in our study population, with most of the patients being overweight, but not obese. This might explain why BMI was not a significant To our knowledge, this is the first study that specifically identifies visceral fat and CT-derived upper abdominal circumference as potential risk factors for severe courses of COVID-19. These indicators can be determined without the need for further imaging simply by performing an automated postprocessing analysis of a standard chest CT scan, provided that it was acquired during routine diagnostic workup. However, it should be noted that a CT-based measurement is obviously not less costly than an anthropomorphic measurement of waist circumference. But other than conventional anthropomorphic measurements, CT-based measurements also allow for an assessment of the visceral and subcutaneous adipose tissue. In addition, even simple measurements, such as measurements of the waist circumference, can be more difficult to obtain in critically ill patients. Given that some COVID-19 patients are extremely ill, such easy-todetermine parameters may be of clinical relevance.

The present proof-of-concept study has several limitations: firstly, anthropomorphic measures were derived from DICOM headers or patient records and might have been reported by the patients with possible bias. Secondly, regarding comorbidities, we also extracted this information from the patient records, assuming a comorbidity was not present if not mentioned in any of the patient records over the last five years. We are aware, that this approach might lead to biased results for the presence of comorbidities. Besides there were also missing data on laboratory data. However, as this data was only provided in the sense of additional clinical information and not included in any analysis, we believe, that this does not affect the results of the present study.

Thirdly, the post-processing application used for the fat measurements was not previously Table 4 gives an overview of differences in fat measures between three patient groups: Group 

o Previous studies suggested an association between obesity and severe COVID-19.

o So far, research focused exclusively on body mass index as a measure of obesity.

o Routine chest CTs allow quantification of subcutaneous and visceral abdominal fat.

o We found a positive association between visceral fat tissue and COVID-19 severity.

o Chest CTs may be a simple tool for risk assessment in patients with COVID-19.

Journal Pre-proof 

Obesity and impaired metabolic health in patients with COVID-19

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Determining the worldwide prevalence of obesity

Visceral and subcutaneous fat quality and cardiometabolic risk

Optimization of abdominal fat quantification on CT imaging through use of standardized anatomic space: a novel approach

Fully automated segmentation and quantification of visceral and subcutaneous fat at abdominal CT: application to a longitudinal adult screening cohort

R: A language and environment for statistical computing

Easily install and load the 'tidyverse'. R package version

Obesity: An Emerging Threat

Interaction of obesity and infections

Adapting to obesity with adipose tissue inflammation

Obesity: The "Achilles heel" for COVID-19?

Visceral adiposopathy: a vascular perspective

Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Impact of visceral adiposity measured by abdominal computed tomography on pulmonary function

Obesity and SARS-CoV-2: a population to safeguard

Obesity and asthma: an inflammatory disease of adipose tissue not the airway

Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)

The Epidemiology of Obesity: A Big Picture

Association of Obesity with Disease Severity among Patients with COVID-19

Obesity and its Implications for COVID-19 Mortality

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality

Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study

Obesity could shift severe COVID-19 disease to younger ages

Obesity and impaired metabolic health in patients with COVID-19

Anatomical patterning of visceral adipose tissue: race, sex, and age variation

visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study

Prediction of the Risk of Laparoscopy-Assisted Gastrectomy by Comparing Visceral Fat Area and Body Mass Index

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study

Adipose tissue location and contribution to postinjury hypercoagulability

Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma

Abdominal fat: standardized technique for measurement at CT

Development of automatic visceral fat volume calculation software for CT volume data

Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome?

(IQR) if not. P-values were obtained with Fisher tests for the count variables age and BMI and with ANOVA for all other variables. Abbreviations: No.: number, SD: standard deviation, BMI: body mass index, COPD: chronic obstructive pulmonary disease